Fluoroestradiol was first developed by Washington University at St. Louis researcher
In 1984, fluoroestradiol (FES) was first developed by researchers Michael J. Welch, PhD from Washington University at St….
In 1984, fluoroestradiol (FES) was first developed by researchers Michael J. Welch, PhD from Washington University at St….
In 1984, the University of Virginia Cancer Center, now Virginia Health, was founded in Charlottesville. The UVA Cancer…
On Jul. 16, 1983, the National Cancer Institute launched the Community Clinical Oncology Program (CCOP) to provide a…
On Feb. 7, 1983, Rita M. Lavelle, head of the U.S. Environmental Protection Agency’s Superfund program to clean…
On Feb. 3, 1983, the University of Southern California Kenneth Norris Jr. Cancer Hospital and Research Institute (USC…
In 1983, The Meyer L. Prentis Comprehensive Cancer Center of Metropolitan Detroit now known as the Karmanos Cancer…
In 1983, the National Cancer Institute formed the Division of Cancer Prevention and Control to accelerate the science…
In 1983, Computerized tomography of the colon (virtual colonoscopy) was proposed as a screening method to identify colon…
In 1983, the Restriction Fragment Length Polymorphisms (RFLPs) was uncovered by the use of restriction endonucleases which cleave…
In 1983, the Community Clinical Oncology Program, an National Cancer Institute (NCI) resource that links community-based physicians with…
In 1983, the Massey Cancer Center opened under the direction of Dr. Walter Lawrence Jr., a surgeon and…
On Jan. 21, 1982, C. Everett Koop was appointed U.S. Surgeon General by President Ronald Reagan. In 1984,…
In 1982, the National Cancer Institute’s (NCI) Physician Data Query (PDQ) cancer information database went online. PDQ is…
In 1982, the Purdue University Institute for Cancer Research (PICR) was established as an National Cancer Institute (NCI)…
In 1982, The Whitehead Institute, was founded as an independent research institution affiliated with Massachusetts Institute of Technology…
In 1982, the Fred Hutch established the Cancer Prevention Program in Seattle, which has made key contributions to…
On Jul. 9, 1981, Frank Ruddle from Yale University, Frank Costantini and Elizabeth Lacy from Oxford, and Ralph…
On Jun. 4, 1981, Genetic Systems announced an Initial Public Offering (IPO) taking advantage of the initial Wall…
In 1981, The University of Hawaii Cancer Center (UH Cancer Center) was founded. The UH Cancer Center’s mission…
In 1981, University of Iowa researcher William Panje introduced the neolarynx, or “voice button,” restoring speech to cancer…
In 1981, the National Cancer Institute (NC) awarded The City of Hope Cancer Center NCI-designation. City of Hope’s…
In 1981, the La Jolla Cancer Research Foundation, the Cancer Center received its National Cancer Institute (NCI)-designation. The…
In 1981, Stanford oncologist Ronald Levy reported the first successful use of monoclonal antibodies, which are laboratory-created molecules…
In 1981, John Wayne Cancer Institute (formerly known as the John Wayne Cancer Clinic) was founded to promote…
In 1981, Hybritech issued its Initial Public Offering (IPO) and raised $12 million, and $33 million in a…
On Dec. 17, 1980, the Health Programs Extension Act of 1980 (P.L. 96-538), introduced by Sen. Edward Kennedy,…
On Jul. 9, 1980, Dr. Vincent T. DeVita, Jr. became the ninth director of the National Cancer Institute…
In 1980, The Holden Cancer Center at University of Iowa was founded with Richard L. DeGowin, M.D. appointed…
In 1980, three of Boston’s oldest and most prestigious Harvard Medical School teaching hospitals – the Peter Bent…
In 1980, the $2 million Gershenson Radiation Oncology Center (GROC) opened as a partnership between Wayne State University’s…